News

News

LNC Therapeutics chooses Luina Bio for the development and GMP manufacturing of its first live bio...

Oct 22, 2019

more +
News

LNC Therapeutics raises €6.2 million for the clinical development of new generation drugs based on...

Sep 5, 2019

more +
News

LNC Therapeutics announces the deployment of a research platform focused exclusively on its gut...

Jun 6, 2019

more +
News

LNC Therapeutics announces the grant of the first worldwide patent relating to the therapeutic...

Mar 26, 2019

more +
News

Dr. Mathieu Simon and Catherine Combot-Plétan join the Board of Directors of biotech firm LNC...

Dec 11, 2018

more +
News

LNC Therapeutics acquires exclusive license for the Christensenella patent from Cornell University

Oct 15, 2018

more +

YSOPIA Bioscience © 2023 - all rights reserved terms and conditions